The L-carnitine market is projected to grow at a considerable CAGR of around 4% during the forecast period (2020-2026). The proper intake of L-carnitine on daily basis facilitates weight management, which is the primary cause of obesity. The L-carnitine supplements are used to offer relief in obesity-related disorders such as diabetes, high blood pressure, heart diseases, and stroke among others. The global adult diabetic population was 425 million in 2018 with the prevalence rate reaching 8.5% as per World Health Organization (WHO). Over 1.6 million mortalities occurred due to diabetes across the globe. L-carnitine aid to prevent damage caused by too much sugar in the body, therefore growing diabetes patients encourages the demand for L-carnitine.